Trademark: 90047516
Status Date
Tuesday, February 14, 2023
Filing Date
Friday, July 10, 2020
Published for Opposition
Tuesday, November 24, 2020
Abandoned Date
Monday, February 13, 2023
5 pharmaceutical products for the treatment of cancer and immune-related diseases and disorders; pharmaceuticals for use in the treatment of oncological disorders and diseases and immune-related diseases and disorders
Feb 14, 2023
Abandonment Notice E-Mailed - After Publication
Feb 14, 2023
Abandonment - After Publication
Feb 13, 2023
Teas Express Abandonment Received
Jul 19, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 15, 2022
Sou Extension 3 Granted
Jul 15, 2022
Sou Extension 3 Filed
Jul 15, 2022
Teas Extension Received
Jan 14, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 12, 2022
Sou Extension 2 Granted
Jan 12, 2022
Sou Extension 2 Filed
Jan 12, 2022
Teas Extension Received
Jul 15, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 13, 2021
Sou Extension 1 Granted
Jul 13, 2021
Sou Extension 1 Filed
Jul 13, 2021
Teas Extension Received
Jan 19, 2021
Noa E-Mailed - Sou Required From Applicant
Nov 24, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 24, 2020
Published For Opposition
Nov 4, 2020
Notification Of Notice Of Publication E-Mailed
Oct 22, 2020
Approved For Pub - Principal Register
Oct 20, 2020
Assigned To Examiner
Aug 7, 2020
New Application Office Supplied Data Entered
Jul 14, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
